TopCare Maximum Strength Urinary Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: TopCare Maximum Strength Urinary Pain Relief
Generic name: PHENAZOPYRIDINE HYDROCHLORIDE
Manufacturer: TOPCO ASSOCIATES LLC
Product type: HUMAN OTC DRUG
SPL set ID: 1662f712-6756-4dcd-bdfa-b4ed28c0d69a
SPL ID: e5d6a5af-cd8f-4afa-9fc4-1a646002ce81
Version: 4
Effective date: 2024-12-18
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:53:46

Harmonized routes table
Harmonized routes
ORAL

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		TopCare Maximum Strength Urinary Pain Relief	openfda.brand_name
generic name		PHENAZOPYRIDINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		TOPCO ASSOCIATES LLC	openfda.manufacturer_name
ndc	package	36800-510-12	openfda.package_ndc
ndc	product	36800-510	openfda.product_ndc
ndc11	package	36800051012	derived:openfda.package_ndc
rxcui		1094147	openfda.rxcui
spl id		e5d6a5af-cd8f-4afa-9fc4-1a646002ce81	id
spl set id		1662f712-6756-4dcd-bdfa-b4ed28c0d69a	set_id
unii		0EWG668W17	openfda.unii

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

Warnings Do not exceed recommended dosage

Adverse event summaries are temporarily unavailable. Other product information remains available.